Efficacy and Safety of Ulotaront in the Treatment of Schizophrenia: Results of Two 6-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials

被引：0
|
作者：
Kane, John [1 ]
Dworak, Heather [1 ]
Koblan, Kenneth [1 ]
Szegedi, Armin [1 ]
Goldman, Robert [1 ]
Li, Yan [1 ]
Fitzgerald, Alison [1 ]
Loebel, Antony [1 ]
Marder, Stephen [1 ]
机构：
[1] Sunovion Pharmaceut Inc, Teaneck, NJ USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2023年 / 48卷
关键词：
Schizophrenia (SCZ); TAAR1; Phase III Trial; Clinical Trial; Ulotaront;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P495
引用
收藏
页码：351 / 351
页数：1
相关论文
共 50 条
  • [31] Treatment of Excessive Sleepiness in Patients With OSA: Efficacy and Safety Results of a 6-Week, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Trial of JZP-110
    Strollo, Patrick
    Redline, Susan
    Hedner, Jan
    Collop, Nancy
    Lorch, Daniel
    Chen, Dan
    Li, Joan
    Carter, Lawrence
    Lee, Lawrence
    Black, Jed
    Pepin, Jean Louis
    CHEST, 2017, 152 (04) : 1092A - 1093A
  • [32] Safety and efficacy of tomoxetine for ADHD in two double-blind, placebo-controlled trials
    Allen, AJ
    Spencer, TJ
    Heiligenstein, JH
    Faries, DE
    Kelsey, DK
    Laws, HF
    Wernicke, J
    Kendrick, KL
    Michelson, D
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 32S - 33S
  • [33] Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials
    Grossberg, George T.
    Kohegyi, Eva
    Mergel, Victor
    Josiassen, Mette Krog
    Meulien, Didier
    Hobart, Mary
    Slomkowski, Mary
    Baker, Ross A.
    McQuade, Robert D.
    Cummings, Jeffrey L.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2020, 28 (04): : 383 - 400
  • [34] Lurasidone monotherapy for the treatment of bipolar I depression: results of a 6-week, double-blind, placebo-controlled study
    Loebel, A.
    Cucchiaro, J.
    Silva, R.
    Sarma, K.
    Kroger, H.
    Calabrese, J. R.
    Sachs, G.
    BIPOLAR DISORDERS, 2013, 15 : 138 - 138
  • [35] Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: A pooled post hoc analysis of double-blind, placebo-controlled 6-week studies
    Costamagna, Isabella
    Calisti, Fabrizio
    Cattaneo, Agnese
    Hsu, Jay
    Tocco, Michael
    Pikalov, Andrei
    Goldman, Robert
    EUROPEAN PSYCHIATRY, 2021, 64 (01)
  • [36] OBSTRUCTIVE SLEEP APNEA: EFFICACY AND SAFETY RESULTS OF A 6-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED-WITHDRAWAL TRIAL OF SOLRIAMFETOL (JZP-110)
    Strollo, P. J.
    Redline, S.
    Hedner, J.
    Collop, N.
    Chen, D.
    Li, J.
    Carter, L. P.
    Lee, L.
    Black, J.
    Pepin, J. -L.
    SLEEP MEDICINE, 2017, 40 : E316 - E316
  • [37] Efficacy and Safety of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study
    Saito, Takuya
    Sugimoto, Saori
    Sakaguchi, Reiko
    Nakamura, Hiroshi
    Ishigooka, Jun
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2022, 32 (01) : 12 - 23
  • [38] Efficacy and safety of oxycodone DETERx: results of a randomized, double-blind, placebo-controlled phase III study
    Kopecky, E.
    O'Connor, M.
    Varanasi, R.
    Saim, S.
    Fleming, A.
    JOURNAL OF PAIN, 2015, 16 (04): : S87 - S87
  • [39] EFFICACY AND SAFETY OF INCOBOTULINUMTOXINA IN THE TREATMENT OF UPPER FACIAL LINES: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY
    Kerscher, Martina
    Rzany, Berthold
    Prager, Welf
    Trevidic, Patrick
    Inglefield, Christopher
    TOXICON, 2018, 156 : S60 - S60
  • [40] Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study
    Ogasa, Masaaki
    Kimura, Tatsuya
    Nakamura, Mitsutaka
    Guarino, John
    PSYCHOPHARMACOLOGY, 2013, 225 (03) : 519 - 530
12345